Stock exchange release no 9-2005/06 - Report for Q3 2005/06

• In Q3, revenue was DKK 173m against DKK 170m in Q3 2004/05, up 2 per cent (2 per cent reported in local currencies). In the period 1 October 2005 to 30 June 2006, revenue increased by 7 per cent (5 per cent reported in local currencies) to DKK 513m.
• Revenue within the strategically most important business areas – Respiratory Care, Cardiology and Neurology – increased by 6 per cent (6 per cent reported in local currencies) in Q3 2005/06.
• Sales of new products increased by 15 per cent in Q3 relative to Q2 and are developing as expected. The growth is attributable, in particular, to continued favourable sales trends within laryngeal masks and the ventilation products SPUR II and Mark IV.
• In autumn 2005, legal proceedings were instituted against Ambu by the British company LMA before a German court with a claim being set up that Ambu with its laryngeal mask had infringed a German patent on a minor product detail. According to a recently passed judgment, Ambu is infringing the German patent in the German market. Ambu has already developed a new version of the laryngeal mask with the same unique properties, and this version is ready for sale in the German market. Regardless of the final outcome of the case, it is not expected to have any significant impact on revenue or earnings.
• Operating profit before amortisation of goodwill (EBITA) was DKK 21m in Q3 against DKK 19m in the same period last year. In the period 1 October 2005 to 30 June 2006, EBITA increased to DKK 51m against DKK 45m in the same period last year, up 13 per cent.
• Profit before tax was DKK 16m in Q3 against DKK 15m in the same period last year. In the period 1 October 2005 to 30 June 2006, profit before tax was DKK 43m against DKK 33m in the same period last year, up 30 per cent.
• The free cash flow totalled DKK 19m in Q3 2005/06 against DKK 4m in the same period last year. In the period 1 October 2005 to 30 June 2006, the free cash flow was DKK 35m against DKK 1m in the same period last year.
• For FY 2005/06 (1 October 2005 - 30 September 2006) as a whole, revenue is expected to be in the region of DKK 720m, and operating profit (EBITA) is expected to be in the region of DKK 90m. Profit before tax is expected to be in the region of DKK 80m. Furthermore, a positive free cash flow is expected.

Contact: K.E. Birk, tel. +45 72 25 20 00, email: keb@ambu.com

Click on the attached file below to download the full stock exchange release.

Report for Q3 2005/06 (English)

Report for Q3 2005/06 (Danish)